Meridian Bioscience
VIVO
$33.97
Share price
0.00%
Change (1 day)
24.02%
Change (1 year)
Categories
Operating Margin for Meridian Bioscience (VIVO)
Operating Margin as of April 2024 (TTM): 16.31%
According to Meridian Bioscience's latest financial reports and stock price the company's current Operating Margin is 16.31%. At the end of 2022 the company had an Operating Margin of 16.31%.
Operating Margin history for Meridian Bioscience from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 16.31% | -42.68% |
| 2021 | 28.45% | 21.73% |
| 2020 | 23.37% | 48.89% |
| 2019 | 15.70% | 10.36% |
| 2018 | 14.22% | -21.6% |
| 2017 | 18.14% | -29.75% |
| 2016 | 25.83% | -8.61% |
| 2015 | 28.26% | 2.42% |
| 2014 | 27.59% | -9.23% |
| 2013 | 30.40% | 6.12% |
| 2012 | 28.65% | 12.98% |
| 2011 | 25.36% | -12.42% |
| 2010 | 28.95% | -12.97% |
| 2009 | 33.26% | 1% |
| 2008 | 32.94% | 10.41% |
| 2007 | 29.83% | 15.29% |
| 2006 | 25.88% | 22.76% |
| 2005 | 21.08% | 27.17% |
| 2004 | 16.58% | -5.81% |
| 2003 | 17.60% | 26.18% |
| 2002 | 13.95% | -152.89% |
| 2001 | -26.37% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | -13.12% | 🇺🇸 USA |
 Becton Dickinson BDX | 9.46% | -42.00% | 🇺🇸 USA |
 Hologic HOLX | 32.66% | 100.25% | 🇺🇸 USA |
 QuidelOrtho QDEL | 2.15% | -86.82% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.